Brochure Fillers - Flipbook - Page 25
Clinical Results
Neauvia’s advanced formulation, combining PEGylated Hyaluronic Acid
(HA) with Calcium Hydroxyapatite (CaHA), has been demonstrated to
effectively address skin and subcutaneous tissue concerns, in particular, the
correction of disorders and the correction of mid-face volume deficit.1 The
collected data highlight an efficient mechanical effect of the PEGylated
polymeric acid matrix enriched with low concertation of CaHA, aligning with
other evidence in vitro and in vivo.1
1. Zerbinati N, D’Este E, De Silvestri A, Zullino M, Rabbiosi G, Guida S, Kubik P, Stabile G, Mocchi R, Barlusconi C et al. Efficacy of Pegylated Hyaluronic Acid filler enriched
with Calcium Hydroxyapatite: a 24-week post-market, observational, prospective, open-label, single-center study. J. Funct. Biomater. 2023, 14, 345. https://doi.org/10.3390/jfb14070345.
